PHASE 1/2 STUDY OF AGENT-797, AN ALLOGENEIC INVARIANT NATURAL KILLER T (INKT) CELL THERAPY, IN SUBJECTS WITH MODERATE TO SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) SECONDARY TO SARS-COV-2 (COVID-19)

被引：2
|
作者：
Purbhoo, Marco [1 ]
Yigit, Burcu [1 ]
Michelet, Xavier [1 ]
Smith, Rachel [1 ]
Moskowitz, Darrian [1 ]
Kirby, Maurice [2 ]
Buffa, Alexa [2 ]
De Munari, Sonia [1 ]
Feliu, Waldo Ortuzar [2 ]
Van Besien, Koen [3 ]
Stevens, Don [4 ]
Exley, Mark [1 ]
Hammond, Terese [5 ]
机构：
[1] MiNK Therapeut, Lexington, MA USA
[2] Agenus Inc, Lexington, MA USA
[3] Weil Cornell Med, New York, NY USA
[4] Norton Canc Ctr, Louisville, KY USA
[5] Providence St Johns Hlth Ctr, Santa Monica, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0649
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
649
引用
收藏
页码：A680 / A680
页数：1
相关论文
共 50 条
  • [1] A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
    Terese C. Hammond
    Marco A. Purbhoo
    Sapana Kadel
    Jerome Ritz
    Sarah Nikiforow
    Heather Daley
    Kit Shaw
    Koen van Besien
    Alexandra Gomez-Arteaga
    Don Stevens
    Waldo Ortuzar
    Xavier Michelet
    Rachel Smith
    Darrian Moskowitz
    Reed Masakayan
    Burcu Yigit
    Shannon Boi
    Kah Teong Soh
    John Chamberland
    Xin Song
    Yu Qin
    Ilya Mishchenko
    Maurice Kirby
    Valeriia Nasonenko
    Alexa Buffa
    Jennifer S. Buell
    Dhan Chand
    Marc van Dijk
    Justin Stebbing
    Mark A. Exley
    Nature Communications, 15
  • [2] A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
    Hammond, Terese C.
    Purbhoo, Marco A.
    Kadel, Sapana
    Ritz, Jerome
    Nikiforow, Sarah
    Daley, Heather
    Shaw, Kit
    van Besien, Koen
    Gomez-Arteaga, Alexandra
    Stevens, Don
    Ortuzar, Waldo
    Michelet, Xavier
    Smith, Rachel
    Moskowitz, Darrian
    Masakayan, Reed
    Yigit, Burcu
    Boi, Shannon
    Soh, Kah Teong
    Chamberland, John
    Song, Xin
    Qin, Yu
    Mishchenko, Ilya
    Kirby, Maurice
    Nasonenko, Valeriia
    Buffa, Alexa
    Buell, Jennifer S.
    Chand, Dhan
    van Dijk, Marc
    Stebbing, Justin
    Exley, Mark A.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [3] PHASE I STUDIES OF AGENT-797, A NOVEL ALLOGENEIC INVARIANT NATURAL KILLER T (INKT) CELL THERAPY, FOR THE TREATMENT OF PATIENTS WITH SOLID TUMORS OR MULTIPLE MYELOMA
    Stevens, Don
    Mo, Clifton
    Garmezy, Benjamin
    Hamm, John
    Carneiro, Benedito
    Wilky, Breelyn
    Sanborn, Rachel
    El-Khoueiry, Anthony
    Buffa, Alexa
    De Munari, Sonia
    Yigit, Burcu
    Purbhoo, Marco
    Exley, Mark
    Einstein, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A678 - A678
  • [4] Origin of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and COVID-19
    Roger W. Byard
    John Hunsaker
    Michael Tsokos
    Forensic Science, Medicine and Pathology, 2020, 16 : 745 - 745
  • [5] Origin of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and COVID-19
    Byard, Roger W.
    Hunsaker, John
    Tsokos, Michael
    FORENSIC SCIENCE MEDICINE AND PATHOLOGY, 2020, 16 (04) : 745 - 745
  • [6] Acute respiratory distress syndrome during the COVID-19 pandemic: not only SARS-CoV-2
    Sauteur, P. M. Meyer
    Kleger, G. -R.
    Albrich, W. C.
    NEW MICROBES AND NEW INFECTIONS, 2021, 40
  • [7] Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection
    Tali, Seyed Hamid Safiabadi
    LeBlanc, Jason J.
    Sadiq, Zubi
    Oyewunmi, Oyejide Damilola
    Camargo, Carolina
    Nikpour, Bahareh
    Armanfard, Narges
    Sagan, Selena M.
    Jahanshahi-Anbuhi, Sana
    CLINICAL MICROBIOLOGY REVIEWS, 2021, 34 (03)
  • [8] Is SARS-CoV-2 viral load a predictor of mortality in COVID-19 acute respiratory distress syndrome patients?
    Dogan, Lerzan
    Allahverdiyeva, Aytaj
    onel, Mustafa
    Mese, Sevim
    Saka Ersin, Esra
    Anakli, Ilkay
    Sarikaya, Zeynep Tugce
    Zengin, Rehile
    Gucyetmez, Bulent
    Uyar, Neval Yurtturan
    Ozcan, Perihan Ergin
    Kocagoz, Ayse Sesin
    Uysal, Hayriye Kirkoyun
    Akinci, Ibrahim Ozkan
    Agacfidan, Ali
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2022, 50 (11)
  • [9] SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial
    Anastasia Papadopoulou
    George Karavalakis
    Efthymia Papadopoulou
    Aliki Xochelli
    Zoi Bousiou
    Anastasios Vogiatzoglou
    Penelope-Georgia Papayanni
    Aphrodite Georgakopoulou
    Maria Giannaki
    Fani Stavridou
    Ioanna Vallianou
    Maria Kammenou
    Evangelia Varsamoudi
    Vasiliki Papadimitriou
    Chrysavgi Giannaki
    Maria Sileli
    Zoi Stergiouda
    Garyfallia Stefanou
    Georgia Kourlaba
    George Gounelas
    Maria Triantafyllidou
    Eleni Siotou
    Antonia Karaglani
    Eleni Zotou
    Georgia Chatzika
    Anna Boukla
    Apostolia Papalexandri
    Maria-Georgia Koutra
    Dimitra Apostolou
    Georgia Pitsiou
    Petros Morfesis
    Michalis Doumas
    Theodoros Karampatakis
    Nikolaos Kapravelos
    Militsa Bitzani
    Maria Theodorakopoulou
    Eva Serasli
    Grigorios Georgolopoulos
    Ioanna Sakellari
    Asimina Fylaktou
    Stavros Tryfon
    Achilles Anagnostopoulos
    Evangelia Yannaki
    Nature Medicine, 2023, 29 : 2019 - 2029
  • [10] SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial
    Papadopoulou, Anastasia
    Karavalakis, George
    Papadopoulou, Efthymia
    Xochelli, Aliki
    Bousiou, Zoi
    Vogiatzoglou, Anastasios
    Papayanni, Penelope-Georgia
    Georgakopoulou, Aphrodite
    Giannaki, Maria
    Stavridou, Fani
    Vallianou, Ioanna
    Kammenou, Maria
    Varsamoudi, Evangelia
    Papadimitriou, Vasiliki
    Giannaki, Chrysavgi
    Sileli, Maria
    Stergiouda, Zoi
    Stefanou, Garyfallia
    Kourlaba, Georgia
    Gounelas, George
    Triantafyllidou, Maria
    Siotou, Eleni
    Karaglani, Antonia
    Zotou, Eleni
    Chatzika, Georgia
    Boukla, Anna
    Papalexandri, Apostolia
    Koutra, Maria-Georgia
    Apostolou, Dimitra
    Pitsiou, Georgia
    Morfesis, Petros
    Doumas, Michalis
    Karampatakis, Theodoros
    Kapravelos, Nikolaos
    Bitzani, Militsa
    Theodorakopoulou, Maria
    Serasli, Eva
    Georgolopoulos, Grigorios
    Sakellari, Ioanna
    Fylaktou, Asimina
    Tryfon, Stavros
    Anagnostopoulos, Achilles
    Yannaki, Evangelia
    NATURE MEDICINE, 2023, 29 (08) : 2019 - +
12345